APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Gene Test Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tumor Gene Test Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchTumor Gene Test Service Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Gene Test Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tumor Gene Test Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Gene Test Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Gene Test Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tumor Gene Test Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tumor Gene Test Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Tumor Gene Test Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Gene Test Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Gene Test Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tumor Gene Test Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Tumor Gene Test Service Segment by Company

Illumina

BGI Genomics Co.,Ltd.

Agilent Technologies

Macrogen

Pacific Biosciences

10x Genomics

QIAGEN

GEEWIZ

MACROGEN

Oxford Nanopore Technologies

Tumor Gene Test Service Segment by Type

Tumor Tissue

Blood

Tumor Gene Test Service Segment by Application

Medical Institution

Scientific Research Institutions

Pharmaceutical Companies

Individual User

Tumor Gene Test Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Gene Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Gene Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Gene Test Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tumor Gene Test Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Gene Test Service industry.

Chapter 3: Detailed analysis of Tumor Gene Test Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Gene Test Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Gene Test Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tumor Tissue Table 3. Key Players of Blood Table 4. Global Tumor Gene Test Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Institution Table 6. Key Players of Scientific Research Institutions Table 7. Key Players of Pharmaceutical Companies Table 8. Key Players of Individual User Table 9. Global Tumor Gene Test Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Tumor Gene Test Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Tumor Gene Test Service Market Share by Region (2021-2026) Table 12. Global Tumor Gene Test Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Tumor Gene Test Service Market Share by Region (2027-2032) Table 14. Tumor Gene Test Service Industry Trends Table 15. Tumor Gene Test Service Industry Drivers Table 16. Tumor Gene Test Service Industry Opportunities and Challenges Table 17. Tumor Gene Test Service Industry Restraints Table 18. Global Tumor Gene Test Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Tumor Gene Test Service Revenue Market Share by Company (2021-2026) Table 20. Global Tumor Gene Test Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Tumor Gene Test Service Key Company Head Office and Area Served Table 22. Global Tumor Gene Test Service Company, Product Type & Application Table 23. Global Tumor Gene Test Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Tumor Gene Test Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Tumor Gene Test Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tumor Gene Test Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Tumor Gene Test Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Tumor Gene Test Service Revenue Market Share by Type (2021-2026) Table 30. Global Tumor Gene Test Service Revenue Market Share by Type (2027-2032) Table 31. Global Tumor Gene Test Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Tumor Gene Test Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Tumor Gene Test Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Tumor Gene Test Service Revenue Market Share by Application (2021-2026) Table 35. Global Tumor Gene Test Service Revenue Market Share by Application (2027-2032) Table 36. Illumina Company Information Table 37. Illumina Business Overview Table 38. Illumina Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Illumina Tumor Gene Test Service Product Portfolio Table 40. Illumina Recent Development Table 41. BGI Genomics Co.,Ltd. Company Information Table 42. BGI Genomics Co.,Ltd. Business Overview Table 43. BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio Table 45. BGI Genomics Co.,Ltd. Recent Development Table 46. Agilent Technologies Company Information Table 47. Agilent Technologies Business Overview Table 48. Agilent Technologies Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Agilent Technologies Tumor Gene Test Service Product Portfolio Table 50. Agilent Technologies Recent Development Table 51. Macrogen Company Information Table 52. Macrogen Business Overview Table 53. Macrogen Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Macrogen Tumor Gene Test Service Product Portfolio Table 55. Macrogen Recent Development Table 56. Pacific Biosciences Company Information Table 57. Pacific Biosciences Business Overview Table 58. Pacific Biosciences Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Pacific Biosciences Tumor Gene Test Service Product Portfolio Table 60. Pacific Biosciences Recent Development Table 61. 10x Genomics Company Information Table 62. 10x Genomics Business Overview Table 63. 10x Genomics Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. 10x Genomics Tumor Gene Test Service Product Portfolio Table 65. 10x Genomics Recent Development Table 66. QIAGEN Company Information Table 67. QIAGEN Business Overview Table 68. QIAGEN Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. QIAGEN Tumor Gene Test Service Product Portfolio Table 70. QIAGEN Recent Development Table 71. GEEWIZ Company Information Table 72. GEEWIZ Business Overview Table 73. GEEWIZ Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. GEEWIZ Tumor Gene Test Service Product Portfolio Table 75. GEEWIZ Recent Development Table 76. MACROGEN Company Information Table 77. MACROGEN Business Overview Table 78. MACROGEN Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. MACROGEN Tumor Gene Test Service Product Portfolio Table 80. MACROGEN Recent Development Table 81. Oxford Nanopore Technologies Company Information Table 82. Oxford Nanopore Technologies Business Overview Table 83. Oxford Nanopore Technologies Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio Table 85. Oxford Nanopore Technologies Recent Development Table 86. North America Tumor Gene Test Service Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Tumor Gene Test Service Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Tumor Gene Test Service Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Tumor Gene Test Service Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Tumor Gene Test Service Market Size by Country (2021-2026) Table 92. North America Tumor Gene Test Service Market Size by Country (2027-2032) Table 93. Europe Tumor Gene Test Service Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Tumor Gene Test Service Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Tumor Gene Test Service Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Tumor Gene Test Service Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Tumor Gene Test Service Market Size by Country (2021-2026) Table 99. Europe Tumor Gene Test Service Market Size by Country (2027-2032) Table 100. China Tumor Gene Test Service Market Size by Type (2021-2026) & (US$ Million) Table 101. China Tumor Gene Test Service Market Size by Type (2027-2032) & (US$ Million) Table 102. China Tumor Gene Test Service Market Size by Application (2021-2026) & (US$ Million) Table 103. China Tumor Gene Test Service Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Tumor Gene Test Service Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Tumor Gene Test Service Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Tumor Gene Test Service Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Tumor Gene Test Service Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Tumor Gene Test Service Market Size by Country (2021-2026) Table 110. Asia Tumor Gene Test Service Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Tumor Gene Test Service Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Tumor Gene Test Service Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Tumor Gene Test Service Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Tumor Gene Test Service Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Tumor Gene Test Service Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Tumor Gene Test Service Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Tumor Gene Test Service Product Image Figure 2. Global Tumor Gene Test Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Tumor Gene Test Service Market Share by Type: 2025 VS 2032 Figure 4. Tumor Tissue Image Figure 5. Blood Image Figure 6. Global Tumor Gene Test Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Tumor Gene Test Service Market Share by Application: 2025 VS 2032 Figure 8. Medical Institution Image Figure 9. Scientific Research Institutions Image Figure 10. Pharmaceutical Companies Image Figure 11. Individual User Image Figure 12. Global Tumor Gene Test Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 14. Global Tumor Gene Test Service Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Tumor Gene Test Service Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Tumor Gene Test Service Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Tumor Gene Test Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Tumor Gene Test Service Revenue Market Share by Type (2021-2032) Figure 21. Global Tumor Gene Test Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Tumor Gene Test Service Revenue Market Share by Application (2021-2032) Figure 23. North America Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 24. North America Tumor Gene Test Service Market Share by Type (2021-2032) Figure 25. North America Tumor Gene Test Service Market Share by Application (2021-2032) Figure 26. North America Tumor Gene Test Service Market Share by Country (2021-2032) Figure 27. United States Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 28. Canada Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 30. Europe Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Tumor Gene Test Service Market Share by Type (2021-2032) Figure 32. Europe Tumor Gene Test Service Market Share by Application (2021-2032) Figure 33. Europe Tumor Gene Test Service Market Share by Country (2021-2032) Figure 34. Germany Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 35. France Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 37. Italy Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 38. Russia Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 40. China Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 41. China Tumor Gene Test Service Market Share by Type (2021-2032) Figure 42. China Tumor Gene Test Service Market Share by Application (2021-2032) Figure 43. Asia Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 44. Asia Tumor Gene Test Service Market Share by Type (2021-2032) Figure 45. Asia Tumor Gene Test Service Market Share by Application (2021-2032) Figure 46. Asia Tumor Gene Test Service Market Share by Country (2021-2032) Figure 47. Japan Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 51. India Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 52. Australia Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Tumor Gene Test Service Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Tumor Gene Test Service Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Tumor Gene Test Service Market Share by Country (2021-2032) Figure 57. Brazil Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 62. UAE Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 64. Chile Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Tumor Tissue
  • Blood
Applications
  • Medical Institution
  • Scientific Research Institutions
  • Pharmaceutical Companies
  • Individual User
Companies covered
  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • 10x Genomics
  • QIAGEN
  • GEEWIZ
  • MACROGEN
  • Oxford Nanopore Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Tumor Gene Test Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tumor Tissue
  5. 1.2.3 Blood
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Tumor Gene Test Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Institution
  9. 1.3.3 Scientific Research Institutions
  10. 1.3.4 Pharmaceutical Companies
  11. 1.3.5 Individual User
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Tumor Gene Test Service Growth Trends by Region
  14. 1.5.1 Global Tumor Gene Test Service Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Tumor Gene Test Service Market Size by Region (2021-2026)
  16. 1.5.3 Tumor Gene Test Service Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Tumor Gene Test Service Market Dynamics
  1. 2.1 Tumor Gene Test Service Industry Trends
  2. 2.2 Tumor Gene Test Service Industry Drivers
  3. 2.3 Tumor Gene Test Service Industry Opportunities and Challenges
  4. 2.4 Tumor Gene Test Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Tumor Gene Test Service Revenue by Company (2021-2026)
  2. 3.2 Global Tumor Gene Test Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Tumor Gene Test Service Key Company Head office and Area Served
  4. 3.4 Global Tumor Gene Test Service Company, Product Type & Application
  5. 3.5 Global Tumor Gene Test Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Tumor Gene Test Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Tumor Gene Test Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Tumor Gene Test Service Tier 1, Tier 2, and Tier 3
4 Tumor Gene Test Service Market by Type
  1. 4.1 Global Tumor Gene Test Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Tumor Gene Test Service Market Size by Type (2021-2032)
  3. 4.3 Global Tumor Gene Test Service Market Size Share by Type (2021-2032)
5 Tumor Gene Test Service Market by Application
  1. 5.1 Global Tumor Gene Test Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Tumor Gene Test Service Market Size by Application (2021-2032)
  3. 5.3 Global Tumor Gene Test Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Illumina Tumor Gene Test Service Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 BGI Genomics Co.,Ltd.
  8. 6.2.1 BGI Genomics Co.,Ltd. Company Information
  9. 6.2.2 BGI Genomics Co.,Ltd. Business Overview
  10. 6.2.3 BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio
  12. 6.2.5 BGI Genomics Co.,Ltd. Recent Developments
  13. 6.3 Agilent Technologies
  14. 6.3.1 Agilent Technologies Company Information
  15. 6.3.2 Agilent Technologies Business Overview
  16. 6.3.3 Agilent Technologies Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Agilent Technologies Tumor Gene Test Service Product Portfolio
  18. 6.3.5 Agilent Technologies Recent Developments
  19. 6.4 Macrogen
  20. 6.4.1 Macrogen Company Information
  21. 6.4.2 Macrogen Business Overview
  22. 6.4.3 Macrogen Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Macrogen Tumor Gene Test Service Product Portfolio
  24. 6.4.5 Macrogen Recent Developments
  25. 6.5 Pacific Biosciences
  26. 6.5.1 Pacific Biosciences Company Information
  27. 6.5.2 Pacific Biosciences Business Overview
  28. 6.5.3 Pacific Biosciences Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pacific Biosciences Tumor Gene Test Service Product Portfolio
  30. 6.5.5 Pacific Biosciences Recent Developments
  31. 6.6 10x Genomics
  32. 6.6.1 10x Genomics Company Information
  33. 6.6.2 10x Genomics Business Overview
  34. 6.6.3 10x Genomics Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 10x Genomics Tumor Gene Test Service Product Portfolio
  36. 6.6.5 10x Genomics Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 QIAGEN Tumor Gene Test Service Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 GEEWIZ
  44. 6.8.1 GEEWIZ Company Information
  45. 6.8.2 GEEWIZ Business Overview
  46. 6.8.3 GEEWIZ Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GEEWIZ Tumor Gene Test Service Product Portfolio
  48. 6.8.5 GEEWIZ Recent Developments
  49. 6.9 MACROGEN
  50. 6.9.1 MACROGEN Company Information
  51. 6.9.2 MACROGEN Business Overview
  52. 6.9.3 MACROGEN Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 MACROGEN Tumor Gene Test Service Product Portfolio
  54. 6.9.5 MACROGEN Recent Developments
  55. 6.10 Oxford Nanopore Technologies
  56. 6.10.1 Oxford Nanopore Technologies Company Information
  57. 6.10.2 Oxford Nanopore Technologies Business Overview
  58. 6.10.3 Oxford Nanopore Technologies Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio
  60. 6.10.5 Oxford Nanopore Technologies Recent Developments
7 North America
  1. 7.1 North America Tumor Gene Test Service Market Size (2021-2032)
  2. 7.2 North America Tumor Gene Test Service Market Size by Type
  3. 7.2.1 North America Tumor Gene Test Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Tumor Gene Test Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Tumor Gene Test Service Market Share by Type (2021-2032)
  6. 7.3 North America Tumor Gene Test Service Market Size by Application
  7. 7.3.1 North America Tumor Gene Test Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Tumor Gene Test Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Tumor Gene Test Service Market Share by Application (2021-2032)
  10. 7.4 North America Tumor Gene Test Service Market Size by Country
  11. 7.4.1 North America Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Tumor Gene Test Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Tumor Gene Test Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Tumor Gene Test Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Tumor Gene Test Service Market Size (2021-2032)
  2. 8.2 Europe Tumor Gene Test Service Market Size by Type
  3. 8.2.1 Europe Tumor Gene Test Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Tumor Gene Test Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Tumor Gene Test Service Market Share by Type (2021-2032)
  6. 8.3 Europe Tumor Gene Test Service Market Size by Application
  7. 8.3.1 Europe Tumor Gene Test Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Tumor Gene Test Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Tumor Gene Test Service Market Share by Application (2021-2032)
  10. 8.4 Europe Tumor Gene Test Service Market Size by Country
  11. 8.4.1 Europe Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Tumor Gene Test Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Tumor Gene Test Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Tumor Gene Test Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Tumor Gene Test Service Market Size (2021-2032)
  2. 9.2 China Tumor Gene Test Service Market Size by Type
  3. 9.2.1 China Tumor Gene Test Service Market Size by Type (2021-2026)
  4. 9.2.2 China Tumor Gene Test Service Market Size by Type (2027-2032)
  5. 9.2.3 China Tumor Gene Test Service Market Share by Type (2021-2032)
  6. 9.3 China Tumor Gene Test Service Market Size by Application
  7. 9.3.1 China Tumor Gene Test Service Market Size by Application (2021-2026)
  8. 9.3.2 China Tumor Gene Test Service Market Size by Application (2027-2032)
  9. 9.3.3 China Tumor Gene Test Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Tumor Gene Test Service Market Size (2021-2032)
  2. 10.2 Asia Tumor Gene Test Service Market Size by Type
  3. 10.2.1 Asia Tumor Gene Test Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Tumor Gene Test Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Tumor Gene Test Service Market Share by Type (2021-2032)
  6. 10.3 Asia Tumor Gene Test Service Market Size by Application
  7. 10.3.1 Asia Tumor Gene Test Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Tumor Gene Test Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Tumor Gene Test Service Market Share by Application (2021-2032)
  10. 10.4 Asia Tumor Gene Test Service Market Size by Country
  11. 10.4.1 Asia Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Tumor Gene Test Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Tumor Gene Test Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Tumor Gene Test Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Tumor Gene Test Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Tumor Gene Test Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Tumor Gene Test Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Tumor Gene Test Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Tumor Gene Test Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Tumor Gene Test Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Tumor Gene Test Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Tumor Gene Test Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Tumor Gene Test Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Tumor Gene Test Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Tumor Gene Test Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Tumor Gene Test Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Tumor Gene Test Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Tumor Gene Test Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst